cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Castle Biosciences Inc
4 own
2 watching
Current Price
$22.73
$1.68
(7.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
606.58M
52-Week High
52-Week High
36.095
52-Week Low
52-Week Low
15.58
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization606.58M
icon52-Week High36.095
icon52-Week Low15.58
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Castle Biosciences Inc do?
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient s tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Read More
How much money does Castle Biosciences Inc make?
News & Events about Castle Biosciences Inc.
Business Wire
1month ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with IMPACT Melanoma, one of the nation's leading non-profit organizations dedicated to melanoma prevention and early detection, as sunscreen...
Ticker Report
1month ago
Castle Biosciences, Inc. (NASDAQ:CSTL Get Rating) insider Derek J. Maetzold sold 969 shares of the businesss stock in a transaction dated Wednesday, April 12th. The shares were sold at an average price of $22.61, for a total value of $21,909.09. Following the sale, the insider now ...
Business Wire
1month ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 22nd Annual...
Zolmax
1month ago
Castle Biosciences, Inc. (NASDAQ:CSTL Get Rating) Director Daniel Bradbury sold 10,300 shares of the companys stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $22.14, for a total value of $228,042.00. Following the sale, the director now directly ...
Business Wire
2 months ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today shared new performance data from a novel, multi-center, independent cohort demonstrating how the independent risk-stratification of DecisionDx-SCC (the Companys 40-gene...
Frequently Asked Questions
Frequently Asked Questions
What is Castle Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Castle Biosciences Inc shares?
plus_minus_icon
How can I buy Castle Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Castle Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Castle Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Castle Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Castle Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Castle Biosciences Inc?
plus_minus_icon
What percentage is Castle Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Castle Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$22.73
$1.68
(7.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00